LabCorp(R) Scheduled to Present at CIBC World Markets 12th Annual Health Care Conference Read more about LabCorp(R) Scheduled to Present at CIBC World Markets 12th Annual Health Care Conference
Laboratory Corporation of America(R) Announces Third Quarter Results; Growth Strategy Continues to Drive Volume and Price Increases Read more about Laboratory Corporation of America(R) Announces Third Quarter Results; Growth Strategy Continues to Drive Volume and Price Increases
LabCorp(R) Scheduled to Present at UBS Warburg Global Life Sciences Conference Read more about LabCorp(R) Scheduled to Present at UBS Warburg Global Life Sciences Conference
LabCorp's National Genetics Institute Receives FDA Approval for Nucleic Acid Tests for HCV and HIV-1 Read more about LabCorp's National Genetics Institute Receives FDA Approval for Nucleic Acid Tests for HCV and HIV-1
LabCorp(R) Scheduled to Present at the Thomas Weisel Partners Health Care Conference Read more about LabCorp(R) Scheduled to Present at the Thomas Weisel Partners Health Care Conference
LabCorp(R) Scheduled to Present at The Banc of America Securities Annual Investment Conference Read more about LabCorp(R) Scheduled to Present at The Banc of America Securities Annual Investment Conference
LabCorp(R) Scheduled to Present at the UBS Global Life Sciences Conference Read more about LabCorp(R) Scheduled to Present at the UBS Global Life Sciences Conference
LabCorp(R) to Offer Liver Fibrosis Assay HCV FibroSure(TM) Through Exclusive Relationship With BioPredictive Read more about LabCorp(R) to Offer Liver Fibrosis Assay HCV FibroSure(TM) Through Exclusive Relationship With BioPredictive
Laboratory Corporation of America(R) Announces 2003 Third Quarter Results Read more about Laboratory Corporation of America(R) Announces 2003 Third Quarter Results
LabCorp(R) Names Paul R. Billings, MD, PhD As Vice President National Director of Genetics and Genomics Read more about LabCorp(R) Names Paul R. Billings, MD, PhD As Vice President National Director of Genetics and Genomics
